BioMark Diagnostics Inc.
BUX
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.46% | -27.74% | -11.06% | 2,702.92% | 140.63% |
| Total Receivables | 10.43% | 1.61% | 11.45% | 127.24% | -1.40% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.81% | -25.53% | -9.69% | 1,559.21% | 46.56% |
|
|
|||||
| Total Current Assets | -12.81% | -25.53% | -9.69% | 1,559.21% | 46.56% |
| Net Property, Plant & Equipment | 502.19% | -71.92% | -17.47% | -33.14% | -13.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.38% | 44.80% | 3.73% | 1.69% | -6.32% |
| Total Assets | 15.56% | -30.82% | -10.65% | 257.89% | -6.23% |
|
|
|||||
| Total Accounts Payable | 10.32% | -30.47% | 14.62% | -43.71% | 7.41% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -5.27% | 6.07% | -29.66% | 3.98% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 142.38% | -49.39% | -7.30% | 218.07% | -52.20% |
| Total Finance Division Other Current Liabilities | 8,306.67% | -1.64% | 5.17% | 0.00% | -6.45% |
| Total Other Current Liabilities | 8,306.67% | -1.64% | 5.17% | 0.00% | -6.45% |
| Total Current Liabilities | 26.10% | -20.52% | 4.73% | -18.84% | -2.09% |
|
|
|||||
| Total Current Liabilities | 26.10% | -20.52% | 4.73% | -18.84% | -2.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -5.27% | 6.07% | -29.66% | 3.98% |
| Capital Leases | 1,920.42% | -80.84% | -33.72% | -64.58% | -6.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 63.08% | -25.13% | 0.31% | -29.36% | -3.05% |
|
|
|||||
| Common Stock & APIC | 1.73% | -2.01% | 5.42% | 32.59% | -6.00% |
| Retained Earnings | -3.91% | -0.83% | -8.17% | -2.85% | 4.02% |
| Treasury Stock & Other | -- | -- | -- | -- | 24.84% |
| Total Common Equity | -40.23% | -36.49% | -19.42% | 258.74% | 0.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -40.23% | -36.49% | -19.42% | 258.74% | 0.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.23% | -36.49% | -19.42% | 258.74% | 0.35% |
|
|
|||||